Issues related to targeted delivery of proteins and peptides

被引:74
作者
Lu, Yingjuan
Yang, Jun
Sega, Emanuela
机构
[1] Endocyte Inc, W Lafayette, IN 47906 USA
[2] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
关键词
targeted delivery; protein therapeutics; peptide therapeutics; cancer therapy;
D O I
10.1208/aapsj080355
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
While modern genomic and proteomic technology enables rapid screening of novel proteins and peptides as potential drug candidates, design of delivery systems for these biologics remains challenging especially to achieve site-specific pharmacological actions. This article discusses the issues associated with targeted delivery of protein and peptide drugs at physiochemical, physiological, and intracellular levels with a special focus on cancer therapy.
引用
收藏
页码:E466 / E478
页数:13
相关论文
共 113 条
  • [11] Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
    Binétruy-Tournaire, R
    Demangel, C
    Malavaud, B
    Vassy, R
    Rouyre, S
    Kraemer, M
    Plouët, J
    Derbin, C
    Perret, G
    Mazie, JC
    [J]. EMBO JOURNAL, 2000, 19 (07) : 1525 - 1533
  • [12] Brem, 1999, Cancer Control, V6, P436
  • [13] Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates
    Caliceti, P
    Veronese, FM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (10) : 1261 - 1277
  • [14] Chen YX, 2001, CANCER RES, V61, P2434
  • [15] Christiansen J, 2004, MOL CANCER THER, V3, P1493
  • [16] Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif
    Colombo, G
    Curnis, F
    De Mori, GMS
    Gasparri, A
    Longoni, C
    Sacchi, A
    Longhi, R
    Corti, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) : 47891 - 47897
  • [17] Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer
    Connor, JP
    Felder, M
    Hank, J
    Harter, J
    Gan, J
    Gillies, SD
    Sondel, P
    [J]. JOURNAL OF IMMUNOTHERAPY, 2004, 27 (03) : 211 - 219
  • [18] Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
    Curnis, F
    Sacchi, A
    Borgna, L
    Magni, F
    Gasparri, A
    Corti, A
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (11) : 1185 - 1190
  • [19] Coupling tumor necrosis factor-α with αv integrin ligands improves its antineoplastic activity
    Curnis, F
    Gasparri, A
    Sacchi, A
    Longhi, R
    Corti, A
    [J]. CANCER RESEARCH, 2004, 64 (02) : 565 - 571
  • [20] Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
    Curnis, F
    Sacchi, A
    Corti, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) : 475 - 482